Methods for treating or preventing asthma by administering an IL-4R antagonist

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9574004
SERIAL NO

13971334

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods for treating or preventing asthma and associated conditions in a patient. The methods of the present invention comprise administering to a subject in need thereof a therapeutic composition comprising an interleukin-4 receptor (IL-4R) antagonist, such as an anti-IL-4R antibody.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • REGENERON PHARMACEUTICALS, INC.;SANOFI BIOTECHNOLOGY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Ardeleanu, Marius White Plains, US 9 165
Gandhi, Namita A New York, US 9 119
Graham, Neil Croton-on-Hudson, US 52 589
Hamilton, Jennifer Davidson Hopewell Junction, US 7 117
Kirkesseli, Stephanie C Paris, FR 1 30
Kundu, Sudeep New York, US 6 117
Ming, Jeffrey Bridgewater, US 9 117
Radin, Allen New York, US 43 652
Rocklin, Ross E Basking Ridge, US 6 117
Weinstein, Steven P Hartsdale, US 9 125

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Aug 21, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00